🇺🇸 FDA
Patent

US 12384830

Compositions and methods for improving immunotherapy

granted A61KA61K40/11A61K40/30

Quick answer

US patent 12384830 (Compositions and methods for improving immunotherapy) held by Regents of the University of Minnesota expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K40/11, A61K40/30, A61K40/31, A61K40/46